This is a second chance at life for me
These CVOT findings are supported by a real-world study performed in over 3 million patients with T2DM from the United States, in which patients treated with SGLT2is did not have a higher risk of any or lower amputation compared with incretins or other glucose-lowering agents [77]
Hims, Hers, Ro, and Strut dont have it, but ZipHealth does
Frequently Asked Questions Doctor-Guided Medical Weight Loss Learn how prescription GLP-1 medications like semaglutide or tirzepatide may support weight loss when guided by a licensed medical provider and tailored to your health history.
Given the significant differences in mechanism, evidence, regulatory status, and clinical indication, a direct head-to-head comparison of retatrutide and tesamorelin as interchangeable options is not clinically appropriate